30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

ConforMIS Reports 3Q16 Revenue -

ConforMIS posted 3Q16 revenue of US $18.6MM, +34.1% vs. 3Q15. (Product revenue: U.S. $14.9MM, +43%; ex-U.S. $3.4MM, +14%) Growth is as reported.

Product sales breakdown per CFMS:

  • iTotal CR, iUni and iDuo $14.4MM, +13.0% 
  • iTotal PS $4.0MM, +401% (full launch occurred in late 1Q16)


Double-digit growth in base business (iTotal CR and partial knees); base business new orders now exceed pre-recall levels

iTotal PS is becoming the primary product for new surgeon acquisition

Completed enrollment in >800 patient study comparing iTotal CR to leading off-the-shelf knees

Sources: ConforMIS, Inc.; ORTHOWORLD Inc.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.